Nazal at al5
|
Gram Negative |
Ciprofloxacin (Most) |
Amikacin 7%, cafamandole 57%, cefotaxime 50%, tobramycin 30% |
Khosravi et al6
|
Enterobacter (41%), 15% Pseudomonas, 114% E.Coli, 14% Coagulase negative staphylococci, 13% Staphylococcus aureus and 0.79% Proteus
|
– |
Pseudomonas resistant to cefixime 71%, Coagulase negative staphylococci resistant to oxacillin 84% |
McShane et al7
|
Coagulase negative staphylococci |
– |
– |
Amini et al8
|
S. aureus (23.6%), Klebsiella spp. (23.3%), Acintobacter spp. (20.7%), P. aeroginosa (18.2%), E. coli (7.7%), and Enterobacter spp |
– |
– |